An International Delphi Consensus on Defining the Optimal Surgical Composite Outcome in Metastatic Spine Disease
pubmed.ncbi.nlm.nih.gov shows its articles on its own site.
Read the article on pubmed.ncbi.nlm.nih.gov ↗Article · Nov 2025 · 1 min read
In brief
In brief
International spine oncology experts achieved consensus on a composite outcome measure (OSCO-M) for evaluating surgical success in metastatic spine disease patients. The measure incorporates absence of severe adverse events, functional outcomes, and quality-of-care indicators to provide multidimensional assessment of surgical interventions in this complex patient population.
Written by the GCMD Library team from the article.
Statements in this article
Composite measures reflect the multidimensional aspect of the surgical process more than an individual outcome variable in spine oncology.
Composite measures should be used to assess the quality of surgical care in spine oncology.
The optimal surgical composite outcome in metastatic spine disease (OSCO-M) is defined by the absence of SAVES-V2 grade 3 adverse events or higher within 30 days.